Food and Healthcare Press Releases

At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. (Photo: https://mma.prnewswire.com/media/696385/WHA_Global_Health_Agenda.jpg ) ESMO advocated the strengthening of health

People treated with Saxenda(R) (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with diet and exercise. The data were presented this week at both the 25th European

China Venus Medtech (Hangzhou) Inc. announced a partnership agreement for strategic investment and authorization with Keystone Heart. This agreement will grant Venus Medtech the right to exclusively develop, manufacture and sell the 3rd generation

WCG(TM) (WIRB-Copernicus Group(R)) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan.

Adults with haemophilia B who received a single dose Refixia(R) (nonacog beta pegol; N9-GP) achieved greater total factor IX exposure than those treated with rFIXFc (recombinant factor IX-Fc fusion protein). The head-to-head paradigm7 trial also observed

A new long term stability study has shown that haemophilia A treatment NovoEight(R) (turoctocog alfa) remains potent after three months exposure to temperatures of 40ºC.[1] The results were presented today at the WFH 2018 World Congress in Glasgow,

The Mall Shopping Center, Government Savings Bank, leading hospitals and health institutions are co-hosting an annual grand event, "The Mall Health & Beauty Expo 2018" on June 28 – July 4, 2018 at the Grand Hall, G Floor, The Mall Bangkapi.

ASCO Abstract # ERBITUX(R) (cetuximab): 3521, 3534, e15711; avelumab: 9507, 9537, 9090, 9008, 8563, 3057, 4544, e21531, e13603, e18932, e21623, e21620, e21544; tepotinib (c-Met kinase inhibitor): 9082, 9016; M6620 (ATR inhibitor): 2549, e21048; M3814

- Collaboration with Washington University on gut bacteria research could lead to diagnostics, treatment for malnourished children - Study to use Merck's genome-editing technology Merck , a leading science and technology company and leader in genome

For the third consecutive year, Bangkok Hospital and Samitivej Hospital, members of Bangkok Dusit Medical Services (BDMS), won 8 Global Health and Travel Awards (GHT Awards), at the 2018 Asia Pacific Healthcare & Medical Tourism Summit, the leading

Venus Medtech announced that it has entered into a definitive investment agreement with DCP Capital. The investment will be used by Venus Medtech to accelerate the upgrading and internationalization of existing valve products, support the company to

As a company whose purpose is to make the world healthier and happier, premier global nutrition company, Herbalife Nutrition, has wrapped up Extravaganza, its annual education and training event for the Southeast Asia member community. The three-day

Ascensia Diabetes Care today announced that it has now launched its upgraded version of the CONTOUR(R)DIABETES app in 24 countries worldwide. This latest version includes the new My Patterns feature, which uses innovative algorithms to more intelligently

From Heber-principle to digital systems, thoracic surgery has significantly changed and improved over the course of time - so has chest drainage. Ten years ago, chest drainage therapy as we knew it was completely overhauled with the introduction of

LimaCorporate has appointed Mr. Michele Marin as a Member of the Italian Board of Directors as of 27th April 2018 in replacement of Daniele Negrato. This appointment follows the previous announcement regarding Michele Marin appointment as CFO of

Werfen, a global leader in healthcare and life sciences, achieves revenues of 1,337 million euros in 2017, a 13.3% increase against 2016. Excluding the impact of recent acquisitions, sales from organic growth grew by 4.6%. With these results, Werfen

In the iconic Hall of Knights, packed with public and policymakers, Dutch biotech Micreos 'sustainable alternative to antibiotics' was chosen as Europe's most relevant innovation, at the finals of the EU's Ideas from Europe competition. Ideas from Europe

Dr. Srinubabu Gedela, CEO of Pulsus and Omics International, announced 2018 Pulsus European expansion Realizing the great potentialities of the European countries, including Germany, Spain, Netherlands, France and Portugal, Pulsus Group announced the

- Sharp increase in net sales to nearly 18.1 billion euros (+15.7 per cent in currency-adjusted terms; +13.9 per cent in euro terms) - Operating income rises significantly to around 3.5 billion euros - Return on net sales of 19.3 per cent - Strengthened

- Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells - Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards -

- Centre will 'bridge the gap' between scientific research and commercialisation of the medicines of the future - Over GBP60 million of Industrial Strategy investment is being used to develop the new centre Today,the Cell and Gene Therapy Catapult's

Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including Clinical Trial Services, Medicines

FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. (Logo:

Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD* patients using Fisher & Paykel